Royal Bank of Canada’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.4M | Buy |
749,392
+719,921
| +2,443% | +$23.4M | ﹤0.01% | 1272 |
|
|
2025
Q1 | $1.11M | Buy |
29,471
+15,774
| +115% | +$596K | ﹤0.01% | 3075 |
|
|
2024
Q4 | $1.12M | Buy |
13,697
+5,207
| +61% | +$426K | ﹤0.01% | 3051 |
|
|
2024
Q3 | $969K | Sell |
8,490
-2,541
| -23% | -$290K | ﹤0.01% | 3190 |
|
|
2024
Q2 | $832K | Buy |
11,031
+7,742
| +235% | +$584K | ﹤0.01% | 3264 |
|
|
2024
Q1 | $224K | Sell |
3,289
-25,461
| -89% | -$1.73M | ﹤0.01% | 4176 |
|
|
2023
Q4 | $1.81M | Buy |
28,750
+16,804
| +141% | +$1.05M | ﹤0.01% | 2714 |
|
|
2023
Q3 | $609K | Buy |
11,946
+5,926
| +98% | +$302K | ﹤0.01% | 3416 |
|
|
2023
Q2 | $300K | Buy |
6,020
+1,779
| +42% | +$88.7K | ﹤0.01% | 3983 |
|
|
2023
Q1 | $159K | Sell |
4,241
-6,055
| -59% | -$227K | ﹤0.01% | 4443 |
|
|
2022
Q4 | $494K | Buy |
10,296
+9,439
| +1,101% | +$453K | ﹤0.01% | 3679 |
|
|
2022
Q3 | $21K | Buy |
857
+359
| +72% | +$8.8K | ﹤0.01% | 5626 |
|
|
2022
Q2 | $10K | Sell |
498
-2,321
| -82% | -$46.6K | ﹤0.01% | 5921 |
|
|
2022
Q1 | $68K | Sell |
2,819
-5,858
| -68% | -$141K | ﹤0.01% | 5411 |
|
|
2021
Q4 | $207K | Buy |
8,677
+3,790
| +78% | +$90.4K | ﹤0.01% | 4785 |
|
|
2021
Q3 | $124K | Buy |
4,887
+1,965
| +67% | +$49.9K | ﹤0.01% | 5053 |
|
|
2021
Q2 | $66K | Buy |
2,922
+418
| +17% | +$9.44K | ﹤0.01% | 5367 |
|
|
2021
Q1 | $50K | Buy |
2,504
+1,979
| +377% | +$39.5K | ﹤0.01% | 5391 |
|
|
2020
Q4 | $14K | Buy |
525
+305
| +139% | +$8.13K | ﹤0.01% | 5677 |
|
|
2020
Q3 | $11K | Buy |
220
+20
| +10% | +$1K | ﹤0.01% | 5406 |
|
|
2020
Q2 | $6K | Buy |
+200
| New | +$6K | ﹤0.01% | 5521 |
|